Compare $CLDI vs $GRI | Chartloom

Compare

$CLDI vs $GRI

Calidi Biotherapeutics Inc · GRI Bio Inc

CLDI

Calidi Biotherapeutics Inc

GRI

GRI Bio Inc

Compare $CLDI vs $GRI

Comparing Calidi Biotherapeutics Inc and GRI Bio Inc

CLDICalidi Biotherapeutics Inc

GRIGRI Bio Inc

CLDICalidi Biotherapeutics Inc

Market cap

$20M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-94.5%

52W performance

-96.0%

FCF yield

-89.7%

GRIGRI Bio Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-77.8%

52W performance

-96.7%

FCF yield

-338.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLDI

GRI

Detailed metrics comparison

CLDI

Calidi Biotherapeutics Inc

GRI

GRI Bio Inc

Market Cap

CLDI$20M

GRI$3M

Enterprise Value

CLDI$17M

GRI$-8M

Price

CLDI$1.03

GRI$1.74

P/E Ratio

CLDIN/A

GRIN/A

P/S Ratio

CLDI0.00x

GRI0.00x

EV/Sales

CLDI0.00x

GRI0.00x

EV/EBITDA

CLDI0.00x

GRI0.00x

P/B Ratio

CLDI1.27x

GRI0.42x

P/FCF Ratio

CLDIN/A

GRIN/A

EV/FCF

CLDI-0.94x

GRI0.76x

PEG Ratio

CLDIN/A

GRIN/A

Forward P/E (NTM)

CLDIN/A

GRIN/A

Forward P/S (NTM)

CLDIN/A

GRIN/A

Revenue (TTM)

CLDI$0

GRI$0

Revenue Growth (YoY)

CLDIN/A

GRIN/A

Forward Rev Growth

CLDI0.0%

GRI0.0%

Gross Margin (TTM)

CLDI0.0%

GRI0.0%

Operating Margin (TTM)

CLDI0.0%

GRI0.0%

EBITDA Margin (TTM)

CLDI0.0%

GRI0.0%

Net Margin (TTM)

CLDI0.0%

GRI0.0%

FCF Margin (TTM)

CLDIN/A

GRIN/A

Net Income (TTM)

CLDI$-23M

GRI$-10M

FCF (TTM)

CLDI$-18M

GRI$-10M

EPS (TTM)

CLDI-$265.03

GRI-$5.35

ROE (TTM)

CLDI-37285.0%

GRI-13403.0%

ROA (TTM)

CLDI-17613.0%

GRI-10683.0%

ROIC (TTM)

CLDI-30694.0%

GRI-13403.0%

Cash

CLDI$4M

GRI$11M

Debt

CLDI$928K

GRI$0

Net Cash/Debt

CLDI$3M

GRI$11M

Current Ratio (TTM)

CLDI1.68x

GRI10.30x

Quick Ratio (TTM)

CLDI1.55x

GRI9.95x

Debt/Equity (TTM)

CLDI0.30x

GRI0.00x

Debt/Assets (TTM)

CLDI0.0%

GRI0.0%

Interest Coverage (TTM)

CLDIN/A

GRIN/A

Net Debt/EBITDA (TTM)

CLDI0.00x

GRI0.00x

Beta

CLDI1.37

GRI-1.09

52W Performance

CLDI-96.0%

GRI-96.7%

YTD Performance

CLDI-94.5%

GRI-77.8%

% from 52W High

CLDI-96.3%

GRI-97.3%

% from 52W Low

CLDI4.5%

GRI27.9%

Asset Turnover (TTM)

CLDI0.00x

GRI0.00x

FCF Yield (TTM)

CLDI-89.7%

GRI-338.3%

Earnings Yield (TTM)

CLDI-117.9%

GRI-313.6%

Dividend Yield (TTM)

CLDIN/A

GRIN/A

Rule of 40

CLDI0.0

GRI0.0

EV/GP/RG

CLDIN/A

GRIN/A

Ticker research

View CLDI research View GRI research

Metric	CLDI Calidi Biotherapeutics Inc	GRI GRI Bio Inc
Market & Valuation
Market Cap	$20M	$3M
Enterprise Value	$17M	$-8M
Price	$1.03	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	0.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-10M
FCF (TTM)	$-18M	$-10M
EPS (TTM)	-$265.03	-$5.35
ROE (TTM)	-37285.0%	-13403.0%
ROA (TTM)	-17613.0%	-10683.0%
ROIC (TTM)	-30694.0%	-13403.0%
Financial Health
Cash	$4M	$11M
Debt	$928K	$0
Net Cash/Debt	$3M	$11M
Current Ratio (TTM)	1.68x	10.30x
Quick Ratio (TTM)	1.55x	9.95x
Debt/Equity (TTM)	0.30x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	-1.09
52W Performance	-96.0%	-96.7%
YTD Performance	-94.5%	-77.8%
% from 52W High	-96.3%	-97.3%
% from 52W Low	4.5%	27.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-89.7%	-338.3%
Earnings Yield (TTM)	-117.9%	-313.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLDI research	View GRI research

Valuation

P/S Ratio

CLDI

0.00x

GRI

0.00x

EV/FCF

CLDI

-0.94x

GRI

0.76x

Growth & revenue

Forward Revenue Growth

CLDI

0.0%

GRI

0.0%

Profitability & performance

Gross Margin

CLDI

0.0%

GRI

0.0%

ROE

GRI

-13403.0%

CLDI

-37285.0%

FCF Yield %

CLDI

-89.7%

GRI

-338.3%

52-Week Performance

CLDI

-96.0%

GRI

-96.7%

Detailed metrics comparison

CLDI

Calidi Biotherapeutics Inc

GRI

GRI Bio Inc

Market Cap

CLDI$20M

GRI$3M

Enterprise Value

CLDI$17M

GRI$-8M

Price

CLDI$1.03

GRI$1.74

P/E Ratio

CLDIN/A

GRIN/A

P/S Ratio

CLDI0.00x

GRI0.00x

EV/Sales

CLDI0.00x

GRI0.00x

EV/EBITDA

CLDI0.00x

GRI0.00x

P/B Ratio

CLDI1.27x

GRI0.42x

P/FCF Ratio

CLDIN/A

GRIN/A

EV/FCF

CLDI-0.94x

GRI0.76x

PEG Ratio

CLDIN/A

GRIN/A

Forward P/E (NTM)

CLDIN/A

GRIN/A

Forward P/S (NTM)

CLDIN/A

GRIN/A

Revenue (TTM)

CLDI$0

GRI$0

Revenue Growth (YoY)

CLDIN/A

GRIN/A

Forward Rev Growth

CLDI0.0%

GRI0.0%

Gross Margin (TTM)

CLDI0.0%

GRI0.0%

Operating Margin (TTM)

CLDI0.0%

GRI0.0%

EBITDA Margin (TTM)

CLDI0.0%

GRI0.0%

Net Margin (TTM)

CLDI0.0%

GRI0.0%

FCF Margin (TTM)

CLDIN/A

GRIN/A

Net Income (TTM)

CLDI$-23M

GRI$-10M

FCF (TTM)

CLDI$-18M

GRI$-10M

EPS (TTM)

CLDI-$265.03

GRI-$5.35

ROE (TTM)

CLDI-37285.0%

GRI-13403.0%

ROA (TTM)

CLDI-17613.0%

GRI-10683.0%

ROIC (TTM)

CLDI-30694.0%

GRI-13403.0%

Cash

CLDI$4M

GRI$11M

Debt

CLDI$928K

GRI$0

Net Cash/Debt

CLDI$3M

GRI$11M

Current Ratio (TTM)

CLDI1.68x

GRI10.30x

Quick Ratio (TTM)

CLDI1.55x

GRI9.95x

Debt/Equity (TTM)

CLDI0.30x

GRI0.00x

Debt/Assets (TTM)

CLDI0.0%

GRI0.0%

Interest Coverage (TTM)

CLDIN/A

GRIN/A

Net Debt/EBITDA (TTM)

CLDI0.00x

GRI0.00x

Beta

CLDI1.37

GRI-1.09

52W Performance

CLDI-96.0%

GRI-96.7%

YTD Performance

CLDI-94.5%

GRI-77.8%

% from 52W High

CLDI-96.3%

GRI-97.3%

% from 52W Low

CLDI4.5%

GRI27.9%

Asset Turnover (TTM)

CLDI0.00x

GRI0.00x

FCF Yield (TTM)

CLDI-89.7%

GRI-338.3%

Earnings Yield (TTM)

CLDI-117.9%

GRI-313.6%

Dividend Yield (TTM)

CLDIN/A

GRIN/A

Rule of 40

CLDI0.0

GRI0.0

EV/GP/RG

CLDIN/A

GRIN/A

Ticker research

View CLDI research View GRI research

Metric	CLDI Calidi Biotherapeutics Inc	GRI GRI Bio Inc
Market & Valuation
Market Cap	$20M	$3M
Enterprise Value	$17M	$-8M
Price	$1.03	$1.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.42x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	0.76x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-23M	$-10M
FCF (TTM)	$-18M	$-10M
EPS (TTM)	-$265.03	-$5.35
ROE (TTM)	-37285.0%	-13403.0%
ROA (TTM)	-17613.0%	-10683.0%
ROIC (TTM)	-30694.0%	-13403.0%
Financial Health
Cash	$4M	$11M
Debt	$928K	$0
Net Cash/Debt	$3M	$11M
Current Ratio (TTM)	1.68x	10.30x
Quick Ratio (TTM)	1.55x	9.95x
Debt/Equity (TTM)	0.30x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	-1.09
52W Performance	-96.0%	-96.7%
YTD Performance	-94.5%	-77.8%
% from 52W High	-96.3%	-97.3%
% from 52W Low	4.5%	27.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-89.7%	-338.3%
Earnings Yield (TTM)	-117.9%	-313.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLDI research	View GRI research